A Multi-Centre Non-Interventional Study to Assess the Tolerability and Effectiveness of Extended-Release Tacrolimus (LCPT) in De Novo Liver Transplant Patients.

Thomas Soliman Georg P Gyoeri Andreas SalatVladimír MejzlíkGabriela A Berlakovich

Published in: Journal of clinical medicine (2023)

TL was rapidly attained with few dose adaptations after LCPT initiation in de novo liver transplant patients. Liver function rapidly improved, whereas kidney function remained normal. LCPT was well-tolerated in this population.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
systematic review
peritoneal dialysis
prognostic factors
clinical trial
randomized controlled trial
patient reported outcomes